Explore more publications!

Health Monitor Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.

Press releases published on March 18, 2026

Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
2026 MAP Awards presented to 20 organizations for high performance in revenue cycle
VitalHub Reports Fourth Quarter 2025 Results
Alvotech Q4 2025 and Full Year 2025 Financial Results
Ever Joint Claims Evaluated: What the Science Says About EverJoint Joint Support Ingredients
Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results
SnoreStop Throat Spray Claims Evaluated: Effective Anti-Snoring Oral Solution with Clinically Proven Ingredients
ADR Ratio Change

ADR Ratio Change

Extendicare Announces Proposed Changes to Board of Directors
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
Big Ed's Meds Under Investigation: Safe FDA-Approved ED Medications for Men
XOMA Royalty Declares Quarterly Preferred Stock Dividends
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson’s Disease
BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions